Delirium and Medical Comorbidity equips teams to prevent, detect, and treat acute confusional states across hospital, ICU, and long-term care—where SUD, hepatic/renal disease, infection, and polypharmacy often collide. This page turns evidence into bedside steps: risk screens on admission; non-pharmacologic bundles (sleep, orientation, mobility, glasses/hearing aids); and judicious medication use. If you’re comparing a delirium management conference, you’ll find protocols that coordinate medicine, geriatrics, anesthesia, and psychiatry, plus pathways that distinguish alcohol/benzodiazepine withdrawal from sepsis or metabolic drivers. Because transitions are risky, we link to Consultation-Liaison and SUD for discharge linkage and MOUD/AUD starts.

Delirium is a system problem with person-level consequences. We outline medication reviews that reduce anticholinergic burden and sedative stacking; pain and sleep strategies that avoid respiratory suppression; and communication plans that support family re-orientation without restraint. For refractory hyperactive cases, we describe safety-first pharmacology and environmental controls; for hypoactive forms, we emphasize mobilization and nutrition. Equity requires hearing/vision support, language access, and caregiver inclusion. Programs track incidence, LOS, falls, and 30-day readmissions to drive improvement.